Product name: GLICLAZIDE

CAS: 21187-98-4

MF：C15H21N3O3S

MW：323.41

Description: Gliclazide is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea. Gliclazide is the research of SERVIER- A French Multinational. In India original Gliclazide is marketed in original Brand name as " Diamicron XR 60 " by SERVIER subsidiary SERDIA Pharmaceuticals, while other companies promote copies are "Glizid" , Glyloc and Reclide in India . In the Philippines, Servier markets it as Diamicron MR, like in most countries across the world. Many generic equivalents are also available e.g. Glubitor-OD, Clizid. It is not marketed in the United States. A modified-release formulation is also marketed. Its classification has been ambiguous, as literature uses it as both a first-generation  and second-generation sulfonylurea. Gliclazide was proven to protect human pancreatic beta-cells from hyperglycemia-induced apoptosis. It was also shown to have an antiatherogenic effect (preventing accumultaion of fat in arteries) in type 2 diabetes.